Literature DB >> 17923400

Effect of hydroalcoholic extract of Zingiber officinalis rhizomes on LPS-induced rat airway hyperreactivity and lung inflammation.

F Aimbire1, S C Penna, M Rodrigues, K C Rodrigues, R A B Lopes-Martins, J A A Sertié.   

Abstract

Ginger, the rhizome of Zingiber officinalis Roscoe (Zingiberaceae), is a common constituent of diets around the world and its extracts have been reported to exhibit several pharmacological activities. We investigated the effect of crude hydroalcoholic extract of ginger on the rat trachea hyperreactivity (RTHR) and lung inflammation induced by lipopolysaccharide (LPS). Our results demonstrate that ginger extract and celecoxib attenuated RTHR 90 min and 48 h after LPS. Ginger and celecoxib reduced the serum level of prostaglandin (PGE2) and thromboxane (TXA2) 90 min after LPS. Celecoxib and ginger also reduced myeloperoxidase activity and the number of cells in rat bronchoalveolar lavage 48 h post-LPS. On lung parenchyma, ginger and celecoxib reduced the release of PGE2 and TXA2 48 h post-LPS. These results suggest that ginger exerts an anti-inflammatory effect on lung attenuating RTHR and COX metabolites seem to be involved in these processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923400     DOI: 10.1016/j.plefa.2007.08.008

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  12 in total

1.  Effects of ginger and its constituents on airway smooth muscle relaxation and calcium regulation.

Authors:  Elizabeth A Townsend; Matthew E Siviski; Yi Zhang; Carrie Xu; Bhupinder Hoonjan; Charles W Emala
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-11       Impact factor: 6.914

2.  Studies on Shokyo, Kanzo, and Keihi in Kakkonto Medicine on Prostaglandin E2 Production in Lipopolysaccharide-Treated Human Gingival Fibroblasts.

Authors:  Toshiaki Ara; Norio Sogawa
Journal:  Int Sch Res Notices       Date:  2016-10-13

3.  Effects of shinbuto and ninjinto on prostaglandin E2 production in lipopolysaccharide-treated human gingival fibroblasts.

Authors:  Toshiaki Ara; Norio Sogawa
Journal:  PeerJ       Date:  2017-12-01       Impact factor: 2.984

4.  Comparison of anti-inflammatory and analgesic effects of Ginger powder and Ibuprofen in postsurgical pain model: A randomized, double-blind, case-control clinical trial.

Authors:  Farshid Rayati; Fatemeh Hajmanouchehri; Elnaz Najafi
Journal:  Dent Res J (Isfahan)       Date:  2017 Jan-Feb

5.  Effects of shokyo (Zingiberis Rhizoma) and kankyo (Zingiberis Processum Rhizoma) on prostaglandin E2 production in lipopolysaccharide-treated mouse macrophage RAW264.7 cells.

Authors:  Toshiaki Ara; Masanori Koide; Hiroyuki Kitamura; Norio Sogawa
Journal:  PeerJ       Date:  2019-09-17       Impact factor: 2.984

6.  Effect of DHU001, a Polyherbal Formula on Formalin-induced Paw Chronic Inflammation of Mice.

Authors:  Yoon-Hee Cho; In-Kwon Chung; Woo-Hyun Cheon; Hyeung-Sik Lee; Sae-Kwang Ku
Journal:  Toxicol Res       Date:  2011-06

7.  Therapeutic Effect of Chung-Pae, an Experimental Herbal Formula, on Acute Lung Inflammation Is Associated with Suppression of NF- κ B and Activation of Nrf2.

Authors:  Kyun Ha Kim; Do-Hyun Kim; Nara Jeong; Kwan-Il Kim; Yong Ho Kim; Mei Lee; Jun-Yong Choi; Hee Jae Jung; Sung-Ki Jung; Myungsoo Joo
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-26       Impact factor: 2.629

8.  Effect of DHU001, a Polyherbal Formula, on Dinitrofluorobenzene-induced Contact Dermatitis (Type I allergy).

Authors:  Hyeung-Sik Lee; Byung-Chang Lee; Sae-Kwang Ku
Journal:  Toxicol Res       Date:  2010-06

9.  Mouse Single Oral Dose Toxicity Study of DHU001, a Polyherbal Formula.

Authors:  Seong-Soo Roh; Sae-Kwang Ku
Journal:  Toxicol Res       Date:  2010-03

Review 10.  Traditional medicinal plants used for respiratory disorders in Pakistan: a review of the ethno-medicinal and pharmacological evidence.

Authors:  Waqas Younis; Hira Asif; Amber Sharif; Humayun Riaz; Ishfaq Ali Bukhari; Asaad Mohamed Assiri
Journal:  Chin Med       Date:  2018-09-18       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.